Rate My Professor Philip Andrews

Professor Philip Andrews serves as Professor and Head of the School of Chemistry at Monash University. He earned his PhD in Chemistry from the University of Strathclyde in Glasgow in 1992, with a thesis titled 'Synthesis and Characterisation of Novel Alkali Metal Amides'. Before joining Monash as a Research Fellow in 1995, he was an Alexander von Humboldt Fellow at Philipps Universität Marburg, Germany, and held a Royal Society Fellowship at Griffith University in Queensland. At Monash, he received an ARC Queen Elizabeth II Fellowship in 1997, was appointed Lecturer in 2004, Deputy Head of School from 2015 to 2018, Acting Head in 2019, and Head thereafter. Andrews is a Fellow of the Royal Society of Chemistry and the Royal Australian Chemical Institute. He has secured nine major ARC grants since 1998 and a NHMRC grant exceeding $476,000 for developing bismuth-based antibacterial materials.

His research interests encompass main group organometallic chemistry, including novel chiral complexes for asymmetric synthesis and heavy p-block metal complexes; medicinal chemistry focused on bioactive bismuth compounds for anti-inflammatory, anti-tumour, and anti-microbial applications, as well as metallo-drugs against Leishmania; medical imaging using bismuth and rare-earth contrast agents; and green chemistry through solvent-free syntheses and sustainable catalysts. As a founding member of the Monash Centre to Impact Antimicrobial Resistance since 2020, he contributes to industry engagement. Notable publications include 'Medicinal chemistry and biomedical applications of bismuth-based compounds and nanoparticles' (2021), 'Leishmaniasis: current treatment and prospects for new drugs and vaccines' (2009), and 'Metal compounds against neglected tropical diseases' (2018). With 196 research articles, he leads projects such as the ARC Training Centre for Development of Advanced Radiochemical Technologies and Combating Antimicrobial Resistance with Bismuth, Gallium, and Indium.